Takeda is walking away from the last target in a collaboration with Wave Life Scien | Takeda has brandished a termination ...

Sage Therapeutics Inc.’s stock slid 4.7% Thursday, after the biotech said it’s cutting about 33% of its workforce as part of ...

Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on ...

Sage is still waiting for phase 2 results with dalzanemdor in Huntington's disease – the last shot on goal for the positive ...

Retired Rochester Police Investigator Bill Lawler died after 15 years of battling Huntington's. He created a fund that raised ...

Huntington’s Disease is an inherited autosomal dominant neurodegenerative disorder that causes a gradual decline in a ...

Samantha Cox, a Paxton resident, ran her fourth Chicago Marathon on Sunday, Oct. 13, to raise awareness of the Huntington’s ...

The project, which will be conducted by URMC’s Center for Health + Technology, seeks to create objective, digital tools that can provide a clearer picture of how Huntington’s disease advances, ...

Wave Life Sciences' WVE-006 study shows significant promise in treating alpha-1 antitrypsin deficiency. Learn more about WVE ...

The University of Rochester Medical Center will lead a study to determine whether early signs of Huntington's disease can be ...

Huntingtons disease treatment industry is projected to witness a CAGR of 20.8% during the period 2024-2032. This growth can ...

The Northeast Chapter of the Huntington’s Disease Society of America, also known as HDSA, held the Team Hope Walk on Sunday, ...